Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes
Emilia Bober(Moorfields Eye Hospital NHS Foundation Trust), Ian Yeung(Moorfields Eye Hospital NHS Foundation Trust), William Tucker(Moorfields Eye Hospital NHS Foundation Trust), Kristina Frain(Moorfields Eye Hospital NHS Foundation Trust), Joshua Luis(Moorfields Eye Hospital NHS Foundation Trust), Peter Addison, Majid Fotuhi(Moorfields Eye Hospital NHS Foundation Trust), Jonathan Virgo(Guy's and St Thomas' NHS Foundation Trust), Jianfei Ma(Minzu University of China), Richard Lee(Moorfields Eye Hospital), Mark Westcott(Barts Health NHS Trust), Carlos Pavésio(Moorfields Eye Hospital NHS Foundation Trust), Edward Hindle(Moorfields Eye Hospital NHS Foundation Trust), Narciss Okhravi(Moorfields Eye Hospital NHS Foundation Trust)
Cited by 6
Related Papers
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
|Nature Reviews Endocrinology|2019|315
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
|Lara D. Veeken|2008|149
British Ocular Syphilis Study (BOSS): 2-Year National Surveillance Study of Intraocular Inflammation Secondary to Ocular Syphilis
|Investigative Ophthalmology & Visual Science|2014|138
Viral posterior uveitis
|Survey of Ophthalmology|2016|126
Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis
|Survey of Ophthalmology|2016|110